How long does an N=1 experiment need to last?

It depends on the biomarker. Vitamin D serum levels need 12 weeks to reach a plateau. Ferritin responds in 8 to 12 weeks, HRV changes in 6 to 8 weeks, sleep interventions in 2 to 4 weeks. Plan each phase to cover at least half of the biological adaptation time. Shorter experiments almost always produce noise instead of signal.

Is it enough to take a supplement and feel better?

No. Placebo effects account for 20 to 40 percent of subjective improvement in many contexts. Add novelty effect, confirmation bias and regression to the mean. Without a baseline, defined outcome measures and a washout phase, you cannot tell whether the supplement or your expectation caused the change. A single measurement is not an experiment.

What is an ABA design?

ABA stands for baseline (A) → intervention (B) → washout back to baseline (A). Each phase lasts 4 to 12 weeks depending on the biomarker. If your outcome deviates clearly from baseline during B and returns during the second A phase, that is strong evidence for a real effect. The ABAB design repeats this cycle and further reduces confounding risk.

How many data points do I need for a meaningful analysis?

For daily measures like HRV or sleep you need at least 14 data points per phase, ideally 21 to 28. For weekly biomarkers like fasting glucose or blood pressure, 7 to 14 measurements per phase are enough. For serum biomarkers a single measurement per phase can work if phases are long enough. Single measurements are never meaningful. Always use weekly means.

Do I need placebo capsules for a serious experiment?

For most N=1 experiments a clean ABAB design without blinding is sufficient. For subjective outcomes (energy, mood, recovery), blinding adds real value. A partner or pharmacist can prepare identical capsules, some with active compound, some with starch. You only find out after the experiment which phase was active. This eliminates expectation effects on subjective outcomes.

Can I test multiple supplements in parallel to save time?

No. As soon as you change two variables at once, the effect cannot be attributed. If your sleep improves after 4 weeks with magnesium and glycine, you don't know which one worked or whether both did. Stack tests have their place, but they answer a different question. For clean causality: one variable per experiment.

How do I document context variables properly?

Daily log with date, dose, time of intake, sleep duration, training intensity, alcohol, stress and special events. In lab2go you can capture these variables in a structured way and use them as filters later. Consistency matters most: fill in the same fields every day, even when nothing unusual happened. Gaps destroy the analysis.

What statistics do I need for evaluation?

For most N=1 experiments, comparing means plus standard deviation per phase is enough. A difference larger than twice the baseline standard deviation counts as meaningful. Spearman rank correlation shows trends within a phase. A t-test needs more than 30 data points per phase, usually feasible with wearable data. For many questions a clean time-series plot is enough.

Which experiments should I not do without medical supervision?

All off-label medications (e.g. GLP-1 agonists, metformin for anti-aging), peptides, injectable compounds, hormone protocols (TRT, SERMs), high-dose pharmacological actives and interventions with known risks like liver burden. Define stop criteria before you start: which value or symptom triggers immediate discontinuation? Baseline blood panel is mandatory for all pharmacological experiments.

What should I do with null results?

Document and accept them. Null results are as valuable as positive ones. They save money and time. Biohacker communities rarely share null results, which distorts perceived evidence. If your 8-week ashwagandha experiment shows no cortisol drop, that is a real result. Publish it in the lab2go supplement log or in Quantified Self communities.

Insights · Analytics

N=1 Experiments: Self-Tracking Done Right

One variable, 2–4 weeks baseline, 8–12 weeks intervention, washout: how to design N=1 experiments that actually tell you something.

Focus

N=1 experiment self-tracking methodology biohacking evaluation ABA design self-experiment

Analytics Praxis

Published: Apr 13, 2026 • 13 min read

N=1 Experiments: Self-Tracking Done Right

N=1 self-tracking: data, context and clean methodology.

TL;DR: A clean N=1 experiment has one variable, 2–4 weeks baseline, an intervention of biologically adequate duration (2 weeks for sleep, 12 weeks for vitamin D), a washout for reversible interventions and standardized measurements. Without baseline and washout you measure placebo and noise. Without long phases you measure adaptation instead of effect.

This article does not replace medical advice. For experiments with medications, peptides or hormones, work with a doctor.

What N=1 Really Means

N=1 means you are the study lead, study participant and data analyst at the same time. One person, one concrete question, one structured trial. The method is the foundation of the modern biohacker community — from cortisol experiments and CGM diets to sleep protocols. It is also methodologically more demanding than many realize.

The goal is not to produce general conclusions. The goal is to reliably evaluate the personal effect of an intervention on you. A large study shows the average effect across 1,000 people. Your N=1 shows whether you are a responder.

A practical example: A meta-analysis shows magnesium glycinate shortens sleep onset by 7 minutes on average. Your N=1 experiment can show that for you it is 22 minutes — or nothing at all. You need both pieces of information to make a decision. Without methodology you end up at “I think it works,” and that is not a basis for long-term supplementation.

Why Single Cases Deceive

Before you plan an experiment, you need to know the six classic error sources. Each one can simulate an effect that does not exist.

Regression to the mean. If you start an experiment because you feel bad, your state will likely drift back toward average — regardless of your intervention. That drift then gets attributed to the supplement.

Placebo effect. In pain, sleep and mood research, placebos account for 20 to 40 percent of measured effects. That applies to you. The expectation that something works produces measurable biological changes.

Confirmation bias. You pay more attention to data that supports your hypothesis. A good night’s sleep after magnesium gets recorded. The bad night two days later gets forgotten or blamed on “too much coffee.”

Novelty effect. Anything new changes behavior and attention short-term. A new evening routine works for the first two weeks, then the effect disappears — regardless of what you took.

Confounders. Season, training, sleep quality, work stress, alcohol, vacation, menstrual cycle. Each of these variables can influence your outcomes more than your intervention.

Measurement noise. Wearables typically have 5 to 15 percent deviation. Blood pressure varies 10 to 20 mmHg across a day. Blood glucose varies by time of day, meal and sleep. Single measurements are almost always misleading.

For deeper methodology on data quality, read the guide on wearable data quality.

Core Principles for Reliable N=1 Studies

Five principles turn a self-test into an experiment that gives you a real answer.

1. One Variable at a Time

Don’t start three new supplements in parallel. Don’t start a new training program and a new supplement at the same time. Don’t change the dose every three days. Each change needs a complete phase before the next one starts. This is slow, but it is the only method that supports causal claims.

2. Baseline Phase (2–4 Weeks)

Before every experiment you need to capture your current state. Subjective outcomes (sleep quality 1–10, energy 1–10) and objective ones (HRV, sleep duration, weight, blood values). At least 14 data points, ideally 21. Without a baseline you don’t know what has actually changed. To get started, use the biomarker baseline checklist.

3. Intervention Phase With Biologically Sensible Duration

The most common error: phases too short. Biological systems need time to adapt. Overview:

Intervention	Minimum Duration
Sleep protocols (cutoff, darkness)	2–4 weeks
Magnesium for sleep	3–4 weeks
HRV changes	6–8 weeks
Ferritin / iron supplementation	8–12 weeks
Strength training effects	12 weeks
Vitamin D serum level	12 weeks to plateau
Blood lipids (LDL, triglycerides)	8–12 weeks
Ashwagandha on cortisol	6–8 weeks

If you see an “effect” after 10 days, it is almost always placebo or noise.

4. Washout Phase (for Reversible Interventions)

After the intervention comes 2 to 4 weeks without intervention. You watch whether your outcomes return to baseline. If they do, that is strong evidence the effect was actually due to the intervention. If not, either something else changed or the effect is not reversible (e.g. training adaptation).

5. Standardized Measurement

Same time, same conditions, same protocol. Specifically:

HRV: morning, directly after waking, 5 minutes lying down, before drinking water
Blood pressure: 7-day average from two morning and two evening measurements
Weight: morning fasted after bathroom, same scale
Blood glucose (CGM): always compare fasting morning value
Blood tests: same lab, same draw protocol (see blood draw protocol)

Design Patterns for N=1

Three designs cover 90 percent of sensible self-trials.

A) ABA design (baseline → intervention → washout). The simplest pattern. Shows whether the outcome responds reversibly to the intervention. 4 to 12 weeks per phase. Good for a first test of a supplement or lifestyle change.

B) ABAB design (multiple alternation). The gold standard for N=1. You repeat the cycle once, reducing the risk that a confounder explains the effect. If the outcome rises in both B phases and falls in both A phases, that is strong evidence. Duration: 16 to 48 weeks total.

C) Multiple crossover with blinded sequence. Your partner or pharmacist prepares identical capsules, some with active compound, some with starch. You don’t know the order. This eliminates placebo effects but takes more organization. Only worthwhile when you plan to take a supplement for months and a subjective outcome is central.

Four Concrete Example Experiments

Example 1: Magnesium for Sleep Quality

Outcomes: Sleep score (wearable), deep sleep minutes, sleep onset time, subjective recovery (1–10)
Baseline: 2 weeks unchanged
Intervention: 4 weeks of 400 mg magnesium glycinate, 60 minutes before bed
Washout: 2 weeks without magnesium
Analysis: Mean ± standard deviation per phase, compare B vs. A1 and A2

Example 2: Coffee Cutoff

Outcomes: Sleep onset time, nighttime HRV, wake after sleep onset (WASO)
Hypothesis: Last coffee at 2 p.m. improves HRV versus 6 p.m.
Design: 3 weeks 2 p.m. cutoff, 3 weeks 6 p.m. cutoff, repeat in reversed order
Analysis: HRV mean per condition, difference as effect size

Example 3: Ashwagandha and Cortisol

Outcomes: Morning serum cortisol (lab), diurnal saliva profile (4 time points), subjective stress (1–10)
Baseline: Blood draw + saliva profile week 0
Intervention: 8 weeks of 600 mg KSM-66 ashwagandha
Re-test: Blood draw + saliva profile week 8
Optional: 4-week washout, then re-measure

Example 4: CGM Experiment With Meal Order

Outcomes: Glucose peak, time in range (70–140 mg/dl), area under curve 2 h postprandial
Hypothesis: Vegetables → protein → carbs lowers glucose peak versus reversed order
Design: Same meal on 7 days in order A, 7 days in order B
Analysis: Mean glucose peak A vs. B, standard deviation

This example shows: N=1 doesn’t always need weeks. For short-term outcomes like postprandial glucose, a day-by-day comparison is enough. For more methodology, read the insight sprint method.

Statistical Evaluation

You don’t need a PhD in statistics to evaluate an N=1. Four tools cover almost all cases.

1. Mean and standard deviation per phase. For each phase (A1, B1, A2, B2), calculate the average of your outcome and the standard deviation. A difference between two phases counts as meaningful when it exceeds twice the baseline standard deviation.

2. Visual inspection. Plot a time series of all data points and mark phase boundaries. You often see trends with your eye before statistics catches them. A jump in the B phase and a drop in A2 is visually convincing.

3. Spearman rank correlation. Shows trends within a phase. If your HRV rises continuously across weeks 1 to 4 of the B phase, there is a positive correlation between time and outcome.

4. t-test with enough data points. If you have more than 30 measurements per phase (typical for daily wearable data), you can run a paired t-test. P-values below 0.05 are a hint, but not strict proof in N=1 context.

Important: significant statistics require many data points. Often a clean plot plus mean comparison is enough. Don’t overdo the statistics.

Common Mistakes

We see six mistakes in almost all beginners.

Intervention phase too short. 10 days of vitamin D and drawing conclusions — serum is not even at half plateau yet.
Multiple changes at once. New supplement stack plus new training plus new sleep times. No conclusion possible.
Single measurements instead of weekly means. A single HRV value says nothing. The 7-day mean says a lot.
No washout. Without washout you cannot rule out placebo and novelty.
Subjective outcomes without blinding. If you know you’re taking the expensive peptide, you will feel better. Almost guaranteed.
Social media hype as “evidence.” An Instagram before-and-after doesn’t replace an experiment. Many community N=1 are poorly documented and publication-biased.

For iterating supplement stacks, read the guide on supplement stack iteration.

Documentation

The best methodology is worthless without clean documentation. A log belongs to every N=1.

Track daily:

Date and time of intervention (e.g. intake time)
Dose in mg or IU
Side effects (GI issues, headaches, skin changes)
Context variables: sleep duration, training intensity (1–10), stress (1–10), alcohol (units)
Special events (illness, travel, unusual stress)

Exportable data is mandatory. CSV export from your tracking tool allows proper analysis later in spreadsheets or statistics software. lab2go supports this export for all biomarkers, supplement logs and wearable data. For long-term biomarker tracking, see the guide on long-term biomarker tracking.

Ethics and Safety

Not every experiment is harmless. Four rules protect you from unnecessary risk.

No risk experiments without medical supervision. Off-label medications, peptides, injectable compounds, hormone protocols (TRT, SERMs) need medical oversight. Even if you can buy them online.

Define stop criteria before starting. At what value or symptom do you stop? Example: liver enzymes above twice the upper limit, blood pressure above 160/100, resting heart rate above 80 bpm, persistent headache over 3 days.

Baseline blood values before pharmacological experiments. Liver, kidney, complete blood count, CRP, hormone status. Without this baseline you cannot tell whether a later abnormal value was already there.

Keep re-test intervals. With risk-profile interventions, check every 4 to 8 weeks, not only at the end.

Community and Evidence Aggregation

Single N=1 are anecdotes. Many N=1 with clean methodology can become quasi-evidence. Platforms like Reddit (r/Nootropics, r/Supplements), Examine.com and the Quantified Self movement collect such data.

Two warnings: publication bias exists in self-experiments too. Who likes to publish that ashwagandha did nothing for them? Positive results are shared more often. Second: social media hype does not replace scientific grounding. PubMed and Examine.com remain the better references for dosing and expected effects.

Your own clean N=1 is valuable, especially when you share null results. That nudges the community toward better methodology.

lab2go as an N=1 Platform

A clean N=1 needs four components: biomarker trends, supplement log, wearable integration, correlations. lab2go covers all four.

Biomarker trends: Every blood test is stored over time. You see instantly whether your vitamin D reached plateau in the B phase.
Supplement log: Dose, time, product per day. CSV export.
Wearable integration: HRV, sleep, resting heart rate, training intensity synced automatically.
Correlations visible: Cross-views between supplement intake and biomarker trend as a visualization.

Check the features or compare plans and pricing if you want to structure your self-experiments properly.

Conclusion: Three Steps to Your First Clean N=1

Choose one question. Not three. One supplement, one lifestyle variable, one concrete outcome.
Plan three phases. Baseline 2–4 weeks, intervention with biologically sensible duration, washout 2–4 weeks. Write down before starting what you measure and what counts as a hit.
Document daily. Date, dose, context. CSV export at the end. Compare means per phase.

Start today with the biomarker baseline checklist and plan your first experiment in lab2go.

This article does not replace medical advice. For pharmacological or invasive interventions, always consult a doctor. Self-experimenting complements medicine. It does not replace it.

Article FAQ

How long does an N=1 experiment need to last?: It depends on the biomarker. Vitamin D serum levels need 12 weeks to reach a plateau. Ferritin responds in 8 to 12 weeks, HRV changes in 6 to 8 weeks, sleep interventions in 2 to 4 weeks. Plan each phase to cover at least half of the biological adaptation time. Shorter experiments almost always produce noise instead of signal.
Is it enough to take a supplement and feel better?: No. Placebo effects account for 20 to 40 percent of subjective improvement in many contexts. Add novelty effect, confirmation bias and regression to the mean. Without a baseline, defined outcome measures and a washout phase, you cannot tell whether the supplement or your expectation caused the change. A single measurement is not an experiment.
What is an ABA design?: ABA stands for baseline (A) → intervention (B) → washout back to baseline (A). Each phase lasts 4 to 12 weeks depending on the biomarker. If your outcome deviates clearly from baseline during B and returns during the second A phase, that is strong evidence for a real effect. The ABAB design repeats this cycle and further reduces confounding risk.
How many data points do I need for a meaningful analysis?: For daily measures like HRV or sleep you need at least 14 data points per phase, ideally 21 to 28. For weekly biomarkers like fasting glucose or blood pressure, 7 to 14 measurements per phase are enough. For serum biomarkers a single measurement per phase can work if phases are long enough. Single measurements are never meaningful. Always use weekly means.
Do I need placebo capsules for a serious experiment?: For most N=1 experiments a clean ABAB design without blinding is sufficient. For subjective outcomes (energy, mood, recovery), blinding adds real value. A partner or pharmacist can prepare identical capsules, some with active compound, some with starch. You only find out after the experiment which phase was active. This eliminates expectation effects on subjective outcomes.
Can I test multiple supplements in parallel to save time?: No. As soon as you change two variables at once, the effect cannot be attributed. If your sleep improves after 4 weeks with magnesium and glycine, you don't know which one worked or whether both did. Stack tests have their place, but they answer a different question. For clean causality: one variable per experiment.
How do I document context variables properly?: Daily log with date, dose, time of intake, sleep duration, training intensity, alcohol, stress and special events. In lab2go you can capture these variables in a structured way and use them as filters later. Consistency matters most: fill in the same fields every day, even when nothing unusual happened. Gaps destroy the analysis.
What statistics do I need for evaluation?: For most N=1 experiments, comparing means plus standard deviation per phase is enough. A difference larger than twice the baseline standard deviation counts as meaningful. Spearman rank correlation shows trends within a phase. A t-test needs more than 30 data points per phase, usually feasible with wearable data. For many questions a clean time-series plot is enough.
Which experiments should I not do without medical supervision?: All off-label medications (e.g. GLP-1 agonists, metformin for anti-aging), peptides, injectable compounds, hormone protocols (TRT, SERMs), high-dose pharmacological actives and interventions with known risks like liver burden. Define stop criteria before you start: which value or symptom triggers immediate discontinuation? Baseline blood panel is mandatory for all pharmacological experiments.
What should I do with null results?: Document and accept them. Null results are as valuable as positive ones. They save money and time. Biohacker communities rarely share null results, which distorts perceived evidence. If your 8-week ashwagandha experiment shows no cortisol drop, that is a real result. Publish it in the lab2go supplement log or in Quantified Self communities.

Discussion

Community comments coming soon. Until then, we welcome feedback and questions via email.

E-Mail anzeigen